LGR5 and esophageal adenocarcinoma: von Rahden et al.[16] reported LgR5 expression in 35 of 41 (85%) patients with esophageal adenocarcinomas with Barrett’s esophagus, and in 16 of 19 (81%) without Barrett’s esophagus.